Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Surgical treatment for non-small cell lung cancer with ipsilateral pulmonary metastases.

Okamoto T, Iwata T, Mizobuchi T, Hoshino H, Moriya Y, Yoshida S, Yoshino I.

Surg Today. 2013 Oct;43(10):1123-8. doi: 10.1007/s00595-012-0452-x. Epub 2012 Dec 10.

PMID:
23224143
2.

Prognosis of resected non-small cell lung cancer patients with intrapulmonary metastases.

Nagai K, Sohara Y, Tsuchiya R, Goya T, Miyaoka E; Japan Lung Cancer Registration Committee.

J Thorac Oncol. 2007 Apr;2(4):282-6.

3.

Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.

Ruffini E, Filosso PL, Bruna MC, Coni F, Cristofori RC, Mossetti C, Solidoro P, Oliaro A.

Eur J Cardiothorac Surg. 2009 Dec;36(6):1037-44. doi: 10.1016/j.ejcts.2009.05.051. Epub 2009 Aug 18.

PMID:
19692259
4.

Prognostic factors in patients with ipsilateral pulmonary metastasis from non-small cell lung cancer.

Nakagawa T, Okumura N, Miyoshi K, Matsuoka T, Kameyama K.

Eur J Cardiothorac Surg. 2005 Oct;28(4):635-9.

PMID:
16126398
5.

The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system.

Oliaro A, Filosso PL, Cavallo A, Giobbe R, Mossetti C, Lyberis P, Cristofori RC, Ruffini E.

Eur J Cardiothorac Surg. 2008 Aug;34(2):438-43; discussion 443. doi: 10.1016/j.ejcts.2008.03.070. Epub 2008 May 27. Review.

PMID:
18502660
7.

Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis.

Okada M, Tsubota N, Yoshimura M, Miyamoto Y, Nakai R.

Ann Thorac Surg. 1999 Aug;68(2):326-30; discussion 331.

PMID:
10475390
8.

Non-small cell lung cancer with ipsilateral pulmonary metastases: prognosis analysis and staging assessment.

Lee JG, Lee CY, Kim DJ, Chung KY, Park IK.

Eur J Cardiothorac Surg. 2008 Mar;33(3):480-4. doi: 10.1016/j.ejcts.2007.12.005. Epub 2008 Jan 14.

PMID:
18249000
9.

Surgical treatment of primary lung cancer with synchronous brain metastases.

Billing PS, Miller DL, Allen MS, Deschamps C, Trastek VF, Pairolero PC.

J Thorac Cardiovasc Surg. 2001 Sep;122(3):548-53.

PMID:
11547308
10.

Pulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomy.

Okamoto T, Iwata T, Mizobuchi T, Hoshino H, Moriya Y, Yoshida S, Yoshino I.

Eur J Cardiothorac Surg. 2012 Jan;41(1):25-30. doi: 10.1016/j.ejcts.2011.04.010.

11.

Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.

Hsu CP, Hsia JY, Chang GC, Chuang CY, Shai SE, Yang SS, Lee MC, Kwan PC.

J Thorac Cardiovasc Surg. 2009 Aug;138(2):426-33. doi: 10.1016/j.jtcvs.2008.12.035. Epub 2009 Mar 28.

PMID:
19619791
12.

Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.

Nakagiri T, Sawabata N, Funaki S, Inoue M, Kadota Y, Shintani Y, Okumura M.

Interact Cardiovasc Thorac Surg. 2011 May;12(5):733-8. doi: 10.1510/icvts.2010.249896. Epub 2011 Feb 5.

13.

Results of surgery for primary lung cancer based on the new international staging system.

Koike T, Terashima M, Takizawa T, Aoki T, Watanabe T, Akamatsu H.

Jpn J Thorac Cardiovasc Surg. 1999 Jul;47(7):313-7.

PMID:
10481388
14.

Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer.

Martini N, Rusch VW, Bains MS, Kris MG, Downey RJ, Flehinger BJ, Ginsberg RJ.

J Thorac Cardiovasc Surg. 1999 Jan;117(1):32-6; discussion 37-8.

PMID:
9869756
15.

[Curative surgical treatment options for patients with non-small cell lung cancer (NSCLC) and solitary pulmonary metastasis].

Tönnies M, Kollmeier J, Bauer TT, Griff S, Kaiser D.

Pneumologie. 2012 Apr;66(4):218-23. doi: 10.1055/s-0032-1308917. Epub 2012 Apr 4. German.

16.

Additional pulmonary resections after pneumonectomy: actual long-term survival and functional results.

Grodzki T, Alchimowicz J, Kozak A, Kubisa B, Pieróg J, Wójcik J, Bielewicz M, Witkowska D.

Eur J Cardiothorac Surg. 2008 Sep;34(3):493-8. doi: 10.1016/j.ejcts.2008.05.023. Epub 2008 Jun 25.

PMID:
18583143
17.

Does bilobectomy offer satisfactory long-term survival outcome for non-small cell lung cancer?

Icard P, Heyndrickx M, Galateau-Sallé F, Rosat P, Lerochais JP, Gervais R, Zalcman G, Hanouz JL.

Ann Thorac Surg. 2013 May;95(5):1726-33. doi: 10.1016/j.athoracsur.2013.01.071. Epub 2013 Apr 2.

PMID:
23561806
18.

[Long-term survival of personalized surgical treatment of locally advanced non-small cell lung cancer based on molecular staging].

Zhou Q, Shi Y, Chen J, Liu B, Wang Y, Zhu D, Zhang HT, Xu P, Gong Y, Chen G, Wei S, Qiu X, Niu Z, Chen X, Lei Z, Duan L, Wu Z.

Zhongguo Fei Ai Za Zhi. 2011 Feb;14(2):86-106. doi: 10.3779/j.issn.1009-3419.2011.02.15. Chinese. Erratum in: Zhongguo Fei Ai Za Zhi. 2011 Jul 20;14(7):592.

19.

Survival and prognostic factors of surgically resected T4 non-small cell lung cancer.

Osaki T, Sugio K, Hanagiri T, Takenoyama M, Yamashita T, Sugaya M, Yasuda M, Yasumoto K.

Ann Thorac Surg. 2003 Jun;75(6):1745-51; discussion 1751.

PMID:
12822610
20.

Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival.

Bueno R, Richards WG, Swanson SJ, Jaklitsch MT, Lukanich JM, Mentzer SJ, Sugarbaker DJ.

Ann Thorac Surg. 2000 Dec;70(6):1826-31.

PMID:
11156079
Items per page

Supplemental Content

Write to the Help Desk